Research Notes on Cholesterol Controversy
The ENHANCE study is a large-scale trial of cholesterol-lowering drugs. Early results from this study indicate that a combination drug, Vytorin, is no more effective than a single drug, Zocor, and that neither drug helped participants lower their cholesterol to target levels.
5 Important Resources on Cholesterol Controversy
- New York Times: New Questions on Treating Cholesterol
- Business Week: Do Cholesterol Drugs Do Any Good?
- Dr. Mintz: Vytorin and Zetia: What to do now?
- American Heart Association: Statement on ENHANCE study results
- Forbes: Merck, Schering Study Falls Flat
Sponsored Links
10 Latest Headlines on Cholesterol Controversy
Other Resources on Cholesterol Controversy
- CardioSource: ENHANCE Trial
- American College of Cardiology: Statement on ENHANCE Trial
- WSJ Health Blog: Vytorin Recap: What is the Heck is IMT?
User Recommended Links for Cholesterol Controversy
Are we missing any great links? Please Login or Register to be the first to add to this list of recommended links to help others and improve this WisdomCard.
About this WisdomCard
- Contributor: Pat Washburn
- Reviewer: Pat Washburn
- Supervised by: The OrganizedWisdom Physician Review Team
- Last update: Sep. 10, 2008
Each WisdomCard is handcrafted by our team of physician-guided health advocates. Our goal is to make it easy for you to find the most useful health resources for any health topic. In addition to filtering out spam and bad links, WisdomCards highlight tips and warnings, such as:
- Guide Favorite
- Guide Warning
- Scroll down to reach relevant content
- Video
- In Memoriam
Help improve this WisdomCard by suggesting great links.
RSS: 
